Parabilis Medicines, Inc. Share Price

Parabilis Medicines, Inc. Share Price

NASDAQ: PBLS
$28.34
-$0.29 (-1.03%) Last updated on 31 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Parabilis Medicines, Inc. Stock Performance

Open
$28.64
Prev. Close
$28.63
Circuit Range
N/A
Day Range
$27.52 - $28.74
Year Range
$22.71 - $42.48
Volume
42,941
Average Traded
$27.99

Parabilis Medicines, Inc. Share Price Today

As of 1 November 2026, Parabilis Medicines, Inc.'s share price is $28.34. The stock opened at $28.64, compared to its previous close of $28.63. During today's trading session, Parabilis Medicines, Inc.'s share price traded between $27.52 and $28.74, with an average price of $28.13. Over the past 52 weeks, the stock has recorded a high of $42.48 and a low of $22.71. In terms of performance, Parabilis Medicines, Inc.'s share price has risen by 3.83% over the last six months and is up 3.83% on a year-on-year basis.

Parabilis Medicines, Inc. Share Price Chart

Line chart of the Parabilis Medicines, Inc. price trend over the selected period. The price fell overall, ranging from 27.52 to 28.74, ending at 28.33.
$27.52$28.74
L
Show Current Price
H

Parabilis Medicines, Inc. Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
N/A
Revenue (TTM)
N/A
Return On Equity (TTM)
N/A
Profit Margin
N/A
Debt to Equity
N/A
Quarterly Earnings Growth YoY
N/A

Parabilis Medicines, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsJun 2026
Revenue$0.15
Net Profit-$66.96
Net Profit Margin-44640.00%
Income ChangeN/A

About Parabilis Medicines, Inc.

Parabilis Medicines Inc s a clinical-stage biopharmaceutical company. It is focused on the development of medicines targeting protein interactions associated with human diseases. It uses a proprietary platform to develop stabilized helical peptide therapeutics, referred to as Helicons, designed to bind and modulate specific proteins. Its flagship product candidate, zolucatetide, targets the interaction between β-catenin and the T-cell factor (TCF) family of transcription factors within the Wnt/β-catenin signaling pathway, which is associated with cell proliferation and differentiation in multiple cancer types.

Parabilis Medicines, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$32.38
$28.33
-12.45%
Sep 2026
$38.44
$32.36
-17.66%
Aug 2026
$33.02
$39.30
+15.52%
Jul 2026
$26.85
$34.02
+24.66%
Jun 2026
$33.00
$27.29
N/A

PBLS Share Price FAQs